Literature DB >> 19052924

Pregnancy and catastrophic antiphospholipid syndrome.

Jose A Gómez-Puerta1, Jose Sanin-Blair, Claudio Galarza-Maldonado.   

Abstract

Antiphospholipid syndrome (APS) is clearly related to maternal morbidity. The most characteristic feature is pregnancy loss; however, several other serious complications had been reported including fetal growth restriction, uteroplacental insufficiency, fetal distress, pre-eclampsia, and HELLP syndrome. Herein, we review the different aspects of obstetric APS features, with special emphasis on its life-threatening variant known as catastrophic APS (Asherson's syndrome) and its relationship with a thrombotic microangiopathy such as HELLP syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19052924     DOI: 10.1007/s12016-008-8100-3

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  46 in total

Review 1.  Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients.

Authors:  R A Asherson; R Cervera; J C Piette; Y Shoenfeld; G Espinosa; M A Petri; E Lim; T C Lau; A Gurjal; A Jedryka-Góral; H Chwalinska-Sadowska; R J Dibner; J Rojas-Rodríguez; M García-Carrasco; J T Grandone; A L Parke; P Barbosa; C Vasconcelos; M Ramos-Casals; J Font; M Ingelmo
Journal:  Medicine (Baltimore)       Date:  2001-11       Impact factor: 1.889

Review 2.  Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome.

Authors:  José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Silvia Bucciarelli; Josep Font
Journal:  Autoimmun Rev       Date:  2006-07-20       Impact factor: 9.754

3.  Postpartum maternal mortality and cesarean delivery.

Authors:  Catherine Deneux-Tharaux; Elodie Carmona; Marie-Hélene Bouvier-Colle; Gérard Bréart
Journal:  Obstet Gynecol       Date:  2006-09       Impact factor: 7.661

Review 4.  Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases.

Authors:  José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Ronald A Asherson; Mario García-Carrasco; Izaias P da Costa; Danieli C O Andrade; Eduardo F Borba; Alexander Makatsaria; Silvia Bucciarelli; Manuel Ramos-Casals; Josep Font
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 5.  Antiphospholipid antibodies: lessons from the bench.

Authors:  Takao Koike; Miyuki Bohgaki; Olga Amengual; Tatsuya Atsumi
Journal:  J Autoimmun       Date:  2007-03-23       Impact factor: 7.094

Review 6.  Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.

Authors:  D Ware Branch; Munther A Khamashta
Journal:  Obstet Gynecol       Date:  2003-06       Impact factor: 7.661

7.  An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy; a report of 2 cases.

Authors:  M H Ornstein; J H Rand
Journal:  J Rheumatol       Date:  1994-07       Impact factor: 4.666

8.  Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome.

Authors:  R Pauzner; M Dulitzky; H Carp; H Mayan; R Kenett; Z Farfel; A Many
Journal:  J Thromb Haemost       Date:  2003-08       Impact factor: 5.824

Review 9.  Immune recognition at the maternal-fetal interface: overview.

Authors:  J A McIntyre
Journal:  Am J Reprod Immunol       Date:  1992 Oct-Dec       Impact factor: 3.886

Review 10.  Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?

Authors:  Ilaria Cavazzana; Nebuloni Manuela; Cetin Irene; Acaia Barbara; Saino Sara; Borghi Maria Orietta; Tincani Angela; Tedesco Francesco; Meroni Pier Luigi
Journal:  J Autoimmun       Date:  2007-04-06       Impact factor: 7.094

View more
  5 in total

Review 1.  The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.

Authors:  Jin Zhang; Cheng Li; Xiaorong Han; Zhongbo Chen; Binay Kumar Adhikari; Yinghui Wang; Yonggang Wang; Jian Sun
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 2.  Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Authors:  Amelia Ruffatti; Ariela Hoxha; Maria Favaro; Marta Tonello; Anna Colpo; Umberto Cucchini; Alessandra Banzato; Vittorio Pengo
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

3.  A Case of Microangiopathic Antiphospholipid-Associated Syndromes during Pregnancy: Review of the Literature.

Authors:  Nobuhiro Suzumori; Shintaro Obayashi; Kyoko Kumagai; Shinobu Goto; Atsuhiro Yoshida; Mayumi Sugiura-Ogasawara
Journal:  Case Rep Med       Date:  2012-06-28

4.  Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report.

Authors:  Andreas Kronbichler; Renate Frank; Michael Kirschfink; Ágnes Szilágyi; Dorottya Csuka; Zoltán Prohászka; Peter Schratzberger; Karl Lhotta; Gert Mayer
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

Review 5.  Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications.

Authors:  T Marchetti; M Cohen; P de Moerloose
Journal:  Clin Dev Immunol       Date:  2013-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.